[HTML][HTML] A critical overview of targeted therapies for vestibular schwannoma

R Tamura, M Toda - International journal of molecular sciences, 2022 - mdpi.com
Vestibular schwannoma (VS) is a benign tumor that originates from Schwann cells in the
vestibular component. Surgical treatment for VS has gradually declined over the past few …

YAP and TAZ: monocorial and bicorial transcriptional co-activators in human cancers

FL Sardo, V Canu, M Maugeri-Saccà, S Strano… - … et Biophysica Acta (BBA …, 2022 - Elsevier
The transcriptional regulators YAP and TAZ are involved in numerous physiological
processes including organ development, growth, immunity and tissue regeneration. YAP …

Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma

L Laraba, L Hillson, JG De Guibert, A Hewitt… - Brain, 2023 - academic.oup.com
Schwannoma tumours typically arise on the eighth cranial nerve and are mostly caused by
loss of the tumour suppressor Merlin (NF2). There are no approved chemotherapies for …

[HTML][HTML] Hippo pathway in Schwann cells and regeneration of peripheral nervous system

J Wang, H Chen, W Hou, Q Han, Z Wang - Developmental …, 2023 - karger.com
Hippo pathway is an evolutionarily conserved signaling pathway comprising a series of
MST/LATS kinase complexes. Its key transcriptional coactivators YAP and TAZ regulate …

[HTML][HTML] The Hippo signaling pathway in leukemia: function, interaction, and carcinogenesis

N Noorbakhsh, B Hayatmoghadam, M Jamali… - Cancer cell …, 2021 - Springer
Cancer can be considered as a communication disease between and within cells;
nevertheless, there is no effective therapy for the condition, and this disease is typically …

The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases

ML Feltri, MR Weaver, S Belin… - Journal of the Peripheral …, 2021 - Wiley Online Library
Initially identified in Drosophila, the Hippo signaling pathway regulates how cells respond to
their environment by controlling proliferation, migration and differentiation. Many recent …

[HTML][HTML] Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor

T Ivanisevic, M Steklov, B Lechat… - Cancer …, 2023 - ncbi.nlm.nih.gov
Dear Editor, Schwannomas are peripheral nervous system tumors that cause chronic pain,
numbness, and potentially lifethreatening organ dysfunction. Surgery is a conventional …

[HTML][HTML] Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia

B Panizzutti, CC Bortolasci, B Spolding… - International Journal of …, 2021 - mdpi.com
Recent reports suggest a link between positive regulation of the Hippo pathway with bipolar
disorder (BD), and the Hippo pathway is known to interact with multiple other signaling …

Systematic Characterization of the Clinical and Pathological Features of Schwannomas Harboring SH3PXD2A:: HTRA1 Fusion

JC Lee, PH Lee, SC Li, KC Liao, YM Chang, HC Chen… - Modern Pathology, 2024 - Elsevier
The understanding of schwannoma tumorigenesis has been reshaped by the recent
identification of SH3PXD2A:: HTRA1 fusion in 10% of intracranial/spinal schwannomas …

Merlin cooperates with neurofibromin and Spred1 to suppress the Ras–Erk pathway

Y Cui, L Ma, S Schacke, JC Yin… - Human Molecular …, 2020 - academic.oup.com
Abstract The Ras–Erk pathway is frequently overactivated in human tumors.
Neurofibromatosis types 1 and 2 (NF1, NF2) are characterized by multiple tumors of …